Evidence map›Paper›PMID 37505862›Full record

ArticleVeterinary sciences2023

Serum Ferritin in Obese Dogs: Changes and Comparison with Other Analytes.

Lorena Franco-Martínez, Luis Pardo-Marín, Laura Sánchez-Mateos, Alberto Muñoz-Prieto, Juan Diego García-Martínez, José J Cerón, Silvia Martínez-Subiela, Camila P Rubio, Asta Tvarijonaviciute

Open access · goldAbstract read
In one paragraph

Article in Veterinary sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Lorena Franco-MartínezInterdisciplinary Laboratory of Clinical Pathology, Interlab-UMU, Campus of Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.ORCID 0000-0003-3375-4274
Luis Pardo-MarínInterdisciplinary Laboratory of Clinical Pathology, Interlab-UMU, Campus of Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.ORCID 0000-0001-5398-1162
Laura Sánchez-MateosClínica Veterinaria Dinos, Espinardo, 30100 Murcia, Spain.
Alberto Muñoz-PrietoInterdisciplinary Laboratory of Clinical Pathology, Interlab-UMU, Campus of Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.ORCID 0000-0001-6865-8712
Juan Diego García-MartínezInterdisciplinary Laboratory of Clinical Pathology, Interlab-UMU, Campus of Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.ORCID 0000-0003-4209-0107
José J CerónInterdisciplinary Laboratory of Clinical Pathology, Interlab-UMU, Campus of Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.
Silvia Martínez-SubielaInterdisciplinary Laboratory of Clinical Pathology, Interlab-UMU, Campus of Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.ORCID 0000-0002-1524-1558
Camila P RubioInterdisciplinary Laboratory of Clinical Pathology, Interlab-UMU, Campus of Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.ORCID 0000-0002-9293-4147
Asta TvarijonaviciuteInterdisciplinary Laboratory of Clinical Pathology, Interlab-UMU, Campus of Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.ORCID 0000-0002-5323-5001
Universidad de Murcia · ESCentro de Edafología y Biología Aplicada del Segura · ESTeagasc - The Irish Agriculture and Food Development Authority · IE

Funding

Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación (AEI), Spain, and The Eu-ropean Next Generation Funds (NextgenerationEU) RYC2021-034764-IMinisterio de Ciencia e Innovación, Agencia Estatal de Investigación (AEI), Spain, and The European Next Generation Funds (NextgenerationEU) RYC2021-033660-IMinisterio de Universidades of the Government of Spain, financed by the European Un-ion-NextGenerationEU Margarita Salas postdoctoral contract
6 · The paper itself

Abstract

Canine obesity is the most common nutritional disorder and is associated with decreased quality of life and longevity as well as comorbidities including cardiorespiratory, endocrine, oncologic, or orthopaedic disorders. Ferritin is a major acute-phase protein in dogs, increasing during inflammation; however, it could also be affected by other conditions, including trauma, iron metabolism dysregulations, neoplasia, or hypoxia. Higher ferritin levels have been reported in obese humans, but ferritin has not been explored in canine obesity. To evaluate the possible changes in serum ferritin in canine obesity, ferritin levels from lean/normal weight (CG,

Indexed as

acute phase proteinsbiomarkerscanine obesitydogferritinhypoxiainflammation

Identifiers

PMID37505862
PMCPMC10383353
OpenAlexW4384067929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.